-
Something wrong with this record ?
MiR-215-5p Reduces Liver Metastasis in an Experimental Model of Colorectal Cancer through Regulation of ECM-Receptor Interactions and Focal Adhesion
T. Machackova, P. Vychytilova-Faltejskova, K. Souckova, K. Trachtova, D. Brchnelova, M. Svoboda, I. Kiss, V. Prochazka, Z. Kala, O. Slaby,
Language English Country Switzerland
Document type Journal Article
Grant support
16-18257S
Grantová Agentura České Republiky
NLK
Free Medical Journals
from 2009
PubMed Central
from 2009
Europe PubMed Central
from 2009
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2009-01-01
Open Access Digital Library
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2009
- Publication type
- Journal Article MeSH
Background: Growing evidence suggests that miR-215-5p is a tumor suppressor in colorectal cancer (CRC); however, its role in metastasis remains unclear. This study evaluates the effects of miR-215 overexpression on the metastatic potential of CRC. Methods: CRC cell lines were stably transfected with miR-215-5p and used for in vitro and in vivo functional analyses. Next-generation sequencing and RT-qPCR were performed to study changes on the mRNA level. Results: Overexpression of miR-215-5p significantly reduced the clonogenic potential, migration, and invasiveness of CRC cells in vitro and tumor weight and volume, and liver metastasis in vivo. Transcriptome analysis revealed mRNAs regulated by miR-215-5p and RT-qPCR confirmed results for seven selected genes. Significantly elevated levels of CTNNBIP1 were also observed in patients' primary tumors and liver metastases compared to adjacent tissues, indicating its direct regulation by miR-215-5p. Gene Ontology and KEGG pathway analysis identified cellular processes and pathways associated with miR-215-5p deregulation. Conclusions: MiR-215-5p suppresses the metastatic potential of CRC cells through the regulation of divergent molecular pathways, including extracellular-matrix-receptor interaction and focal adhesion. Although the specific targets of miR-215-5p contributing to the formation of distant metastases must be further elucidated, this miRNA could serve as a promising target for CRC patients' future therapeutic strategies.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21001678
- 003
- CZ-PrNML
- 005
- 20210126092803.0
- 007
- ta
- 008
- 210105s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/cancers12123518 $2 doi
- 035 __
- $a (PubMed)33255928
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Machackova, Tana $u Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
- 245 10
- $a MiR-215-5p Reduces Liver Metastasis in an Experimental Model of Colorectal Cancer through Regulation of ECM-Receptor Interactions and Focal Adhesion. / $c T. Machackova, P. Vychytilova-Faltejskova, K. Souckova, K. Trachtova, D. Brchnelova, M. Svoboda, I. Kiss, V. Prochazka, Z. Kala, O. Slaby,
- 520 9_
- $a Background: Growing evidence suggests that miR-215-5p is a tumor suppressor in colorectal cancer (CRC); however, its role in metastasis remains unclear. This study evaluates the effects of miR-215 overexpression on the metastatic potential of CRC. Methods: CRC cell lines were stably transfected with miR-215-5p and used for in vitro and in vivo functional analyses. Next-generation sequencing and RT-qPCR were performed to study changes on the mRNA level. Results: Overexpression of miR-215-5p significantly reduced the clonogenic potential, migration, and invasiveness of CRC cells in vitro and tumor weight and volume, and liver metastasis in vivo. Transcriptome analysis revealed mRNAs regulated by miR-215-5p and RT-qPCR confirmed results for seven selected genes. Significantly elevated levels of CTNNBIP1 were also observed in patients' primary tumors and liver metastases compared to adjacent tissues, indicating its direct regulation by miR-215-5p. Gene Ontology and KEGG pathway analysis identified cellular processes and pathways associated with miR-215-5p deregulation. Conclusions: MiR-215-5p suppresses the metastatic potential of CRC cells through the regulation of divergent molecular pathways, including extracellular-matrix-receptor interaction and focal adhesion. Although the specific targets of miR-215-5p contributing to the formation of distant metastases must be further elucidated, this miRNA could serve as a promising target for CRC patients' future therapeutic strategies.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vychytilova-Faltejskova, Petra $u Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
- 700 1_
- $a Souckova, Kamila $u Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
- 700 1_
- $a Trachtova, Karolina $u Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
- 700 1_
- $a Brchnelova, Dominika $u Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
- 700 1_
- $a Svoboda, Marek $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, 602 00 Brno, Czech Republic.
- 700 1_
- $a Kiss, Igor $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, 602 00 Brno, Czech Republic.
- 700 1_
- $a Prochazka, Vladimir $u Department of Surgery, Faculty Hospital Brno and Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.
- 700 1_
- $a Kala, Zdenek $u Department of Surgery, Faculty Hospital Brno and Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.
- 700 1_
- $a Slaby, Ondrej $u Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic. Department of Biology, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.
- 773 0_
- $w MED00173178 $t Cancers $x 2072-6694 $g Roč. 12, č. 12 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33255928 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210126092758 $b ABA008
- 999 __
- $a ind $b bmc $g 1613976 $s 1121962
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 12 $c 12 $e 20201126 $i 2072-6694 $m Cancers $n Cancers $x MED00173178
- GRA __
- $a 16-18257S $p Grantová Agentura České Republiky
- LZP __
- $a Pubmed-20210105
